For two years running, corrective and preventive action (CAPA) problems have been the most cited FDA Form-483 deficiency during inspections of medical device manufacturers (see the “Recent FDA ...
Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "FDA Inspections - Top FDA 483 Observations and Prevention Strategies" training has been added to ResearchAndMarkets.com's offering. This expanded ...
When FDA oversight detects violations of current good manufacturing practices (CGMPs) at a drug manufacturing facility, the owner is expected to respond with a corrective and preventive actions (CAPA) ...
How do you prevent becoming another FDA statistic? Poor corrective and preventive action (CA/PA) and investigations continue to be among top FDA Form 483 deficiencies issued to drug, biologic, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback